DMRA earnings: a negative outcome, -8.1%

On March 9, 2023, Damora Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.1% in the window around the event. It had already run -28.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.